Sabir khan | Epidemiology | Best Researcher Award

Published on by Cell Biologist

Dr. Sabir khan | Epidemiology | Best Researcher Award

Jinfeng Laboratory, Chongqing | China

Dr. Sabir Khan’s research focuses on transcription factors, gene expression regulation, and the biosynthetic pathways of antibiotics. His work integrates microbiology and synthetic biology to explore the molecular mechanisms underlying fungal and bacterial diseases. He has contributed significantly to understanding antifungal susceptibility and the development of resistance mechanisms in pathogenic microorganisms. In addition, his studies on glioma (brain cancer) investigate microbial interactions and secondary metabolites that may offer therapeutic potential. His research extends to fermentation technology, optimizing microbial processes for enhanced antibiotic production. Dr. Khan’s postdoctoral research emphasizes ecological and synthetic biology approaches to manipulate microbial pathways for improved biosynthetic yields. By combining molecular genetics, microbiological assays, and bioinformatics tools, his work aims to identify regulatory networks and transcriptional controls involved in secondary metabolite production. Through this multidisciplinary approach, Dr. Khan contributes to the advancement of microbial biotechnology and the development of novel antimicrobial and anticancer strategies.

Profiles: Google Scholar | Orcid

Featured Publications: 

Khan, S., Bilal, H., Khan, M. N., Fang, W., Chang, W., Yin, B., Song, N. J., et al. (2024). Interleukin inhibitors and associated risk of candidiasis. Frontiers in Immunology, 28 March 2024.

Khan, S., Bilal, H., Shafiq, M., Zhang, D., Awais, M., Chen, C., Khan, M. N., et al. (2024). Distribution of Aspergillus species and risk factors for Aspergillosis from mainland China: A systematic analysis. Therapeutic Advances in Infectious Disease, 17 April 2024. https://doi.org/10.1177/2049936124xxxxx
(IF: 5.7)

Khan, S., Xu, X., Song, J., Wu, P., Liu, X., Liu, J., Chen, K., Xu, Z., Wu, H., & Zhang, B. (2022). Crosstalk of TetR-like regulator SACE_4839 and a nitrogen regulator for erythromycin biosynthesis. Applied Microbiology and Biotechnology, 106, 12345–12356.

Liu, Y.#, Khan, S.#, Wu, P.#, Liu, L., Li, B., Ni, J., Zhang, H., Chen, K., Wu, H., & Zhang, B. (2021). Uncovering and engineering mini-regulatory network of the TetR-family regulator SACE_0303 for yield improvement of erythromycin in Saccharopolyspora erythraea. Frontiers in Bioengineering and Biotechnology, 9, 715234.

Khan, S.†, Cai, L.†, Bilal, H., Khan, M. N., Fang, W., Zhang, D., & Yao, F. (2023). An 11-year retrospective analysis of candidiasis epidemiology, risk factors, and antifungal susceptibility in a tertiary care hospital in China. Scientific Reports, 13, 5678.

Khan, S.†, Hou, B., Khan, M. N., Shafiq, M., Cai, L.†, Fang, W., Wang, Q., Bilal, H., & Zeng, Y. (2025). A three-year retrospective analysis of microbial species and key biomarkers associated with wound infections in Shantou Hospital, China. Frontiers in Cellular and Infection Microbiology, 15, 15456.

Khan, S., Hameed, M. F., Zafar, I., Bibi, R., Mohany, M., Nazir, S., Kamal, M. A., & Shafiq, M. (2024). Synthesis, characterization, and pharmacological evaluation of Zn4O(BDC)3: Anticancer, antidiabetic, and drug delivery potential. Medicinal Chemistry, 20(3), 145–157.

Arzu Yay | Stem Cell Research | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Arzu Yay | Stem Cell Research | Best Researcher Award

Erciyes University | Turkey

Prof. Arzu Yay is a distinguished researcher in the Department of Histology and Embryology at Erciyes University, Turkey. Her work focuses on cellular and molecular mechanisms underlying tissue development, injury, and repair, with emphasis on immunohistochemical and ultrastructural analyses. Her M.Sc. research examined E-cadherin expression during renal development in the prenatal period, contributing to the understanding of epithelial differentiation in organogenesis. Her Ph.D. focused on nestin expression across different grades of meningiomas and glioblastomas, highlighting neural stem cell marker dynamics in tumor progression. She has conducted significant studies on oxidative stress, neurobiology, and tissue damage, including investigations into the effects of melatonin and vitamin C on alcohol-induced lung injury and nitric oxide synthase immunoreactivity. Her research has also explored tissue-level alterations in diabetes and the histological impacts of hormonal and anesthetic agents. Prof. Yay’s postdoctoral work at the University of Lübeck, Germany, further advanced her expertise in dermatological histopathology. Her contributions have been recognized through multiple national and international awards for excellence in experimental and translational research, particularly in antioxidant mechanisms and radioprotection. Her body of work reflects a strong integration of histological, molecular, and ultrastructural approaches in biomedical sciences.

Profiles: Google Scholar | Scopus

Featured Publications:

Yıldız, K., Efesoy, S. N., Ozdamar, S., Yay, A., Bicer, C., Aksu, R., & Kılıc, E. (2011). Myotoxic effects of levobupivacaine, bupivacaine and ropivacaine in a rat model. Clinical Investigation in Medicine, 34(5), 273–280.

Sarıozkan, S., Bucak, M. N., Canturk, F., Ozdamar, S., Yay, A., Tuncer, P. B., Ozcan, S., Sorgucu, N., & Caner, Y. (2012). The effects of different sugars on motility, morphology and DNA damage during the liquid storage of rat epididymal sperm at 4°C. Cryobiology, 65(2), 93–97.

Sarıozkan, S., Canturk, F., Yay, A., & Akçay, A. (2012). The effect of different storage temperature on sperm parameters and DNA damage in liquid stored New Zealand rabbit spermatozoa. Kafkas Üniversitesi Veteriner Fakültesi Dergisi, 18(3), 475–480.*

Yay, A., Ozdamar, S., Canoz, O., Tucer, B., & Baran, M. (2013). Nestin expression in meningiomas of different grades. Journal of Neurological Sciences (Turkish), 30, 532–540.

Sarıozkan, S., Türk, G., Canturk, F., Yay, A., Eken, A., & Akçay, A. (2013). The effect of bovine serum albumin and fetal calf serum on sperm quality, DNA fragmentation and lipid peroxidation of liquid stored rabbit semen. Cryobiology, 67(1), 1–6.*

Ernst, N., Yay, A., Bíró, T., Tiede, S., Humphries, M., Paus, R., & Kloepper, J. E. (2013). β1 integrin signaling maintains human epithelial progenitor cell survival in situ and controls proliferation, apoptosis and migration of their progeny. PLoS ONE, 8(12), e84356.*

Yay, A., Ozdamar, S., Canoz, O., Baran, M., Tucer, B., & Sonmez, M. F. (2014). Intermediate filament protein nestin is expressed in developing meninges. Bratislava Medical Journal, 115(11), 718–722.*

Long Yu | Biosensor | Best Researcher Award

Published on by Cell Biologist

Assoc. Prof. Dr. Long Yu | Biosensor | Best Researcher Award

Assoc. Prof. Dr. Long Yu | Wuhan University | China

Dr. Long Yu is a highly accomplished Han Chinese researcher, currently serving as a Postdoctoral Fellow in Clinical Medicine at Wuhan University. With a deep passion for pharmaceutical analysis, he has pioneered innovative approaches using lanthanide-based metal-organic frameworks (Ln-MOFs). His academic journey has been marked by excellence, including direct admission to a Ph.D. program and multiple national-level scholarships. Dr. Yu has published over 20 high-impact SCI papers, many in top-tier journals such as Advanced Materials, ACS Nano, and Analytical Chemistry. Recognized for his independent research capabilities, he has secured major national funding, including the NSFC Youth Project and China Postdoctoral Science Foundation grant. His work is shaping the future of biosensing and molecular diagnostics, especially in nucleic acid detection. Dr. Yu’s remarkable academic achievements, innovative research direction, and collaborative impact make him an outstanding candidate for the Best Researcher Award.

Publication Profile: 

Orcid

Education:

Dr. Long Yu’s educational background reflects a consistent trajectory of academic excellence. He completed his Bachelor of Science in Pharmacy at Shihezi University, where he graduated and was directly admitted to a Ph.D. program without an entrance exam. He pursued a Direct-Ph.D. in Pharmacy at Wuhan University, under the mentorship of Prof. Yuxiu Xiao. His doctoral research focused on the rational design and application of programmable lanthanide-based metal-organic frameworks (Ln-MOFs) in pharmaceutical analysis. Currently, he is a Postdoctoral Fellow in Clinical Medicine at Wuhan University, guided by Professors Gaosong Wu and Xiang Zhou. Through his academic journey, Dr. Yu has demonstrated strong interdisciplinary capabilities, combining pharmaceutical sciences, materials chemistry, and biosensing technology to advance the field of molecular diagnostics.

Experience:

Dr. Long Yu has cultivated deep expertise in biosensors and pharmaceutical analysis throughout his academic and research journey. He is currently a Postdoctoral Fellow in Clinical Medicine at Wuhan University, working on translational biosensing technologies with Professors Gaosong Wu and Xiang Zhou. He earned his Ph.D. in Pharmacy at Wuhan University under the supervision of Prof. Yuxiu Xiao, where he led several high-impact research projects on programmable metal-organic frameworks (MOFs). His undergraduate foundation was built at Shihezi University , where he graduated among the top of his class. Dr. Yu has served as the principal investigator for five competitive research grants, including prestigious national funding. His academic footprint includes 21 SCI-indexed publications and significant contributions to both theoretical research and practical biosensor development. He excels at multidisciplinary collaboration, combining chemistry, materials science, and clinical application—demonstrating both leadership and innovation in his research.

Awards and Honors:

Dr. Long Yu has received multiple accolades that highlight his academic and research excellence. During his Ph.D., he was awarded the National Scholarship for Graduate Students twice, a prestigious recognition of outstanding academic performance and research capabilities in China. He also received the 1st Prize for Oral Presentation at the National Academic Symposium for Pharmacy Postgraduates in , and the Excellent Poster Award at the 9th National Conference on Drug Analysis in the same year. In addition to academic awards, he has secured several competitive grants as the Principal Investigator, including the National Natural Science Foundation of China Youth Project, the China Postdoctoral Science Foundation General Program, and the Hubei Province Postdoctoral Innovation Talent Program. These achievements demonstrate both national-level recognition and institutional confidence in his independent research potential, marking him as one of the leading young scientists in his field.

Research Focus:

Dr. Long Yu’s research is centered on the rational design of programmable lanthanide-based metal-organic frameworks (Ln-MOFs) for pharmaceutical analysis and biosensing applications. His work bridges materials science and biomedical engineering, enabling high-performance detection platforms for nucleic acids, neurotransmitters, kinases, and epigenetic modifications. He has developed Ln-MOF-integrated systems with excellent selectivity, sensitivity, and biocompatibility for real-time monitoring and clinical diagnostics. A notable feature of his research is the integration of MOF materials with cutting-edge technologies such as CRISPR-Cas, nanozymes, and multivariate sensing platforms. His innovative designs contribute to amplification-free gene mutation detection, ultra-efficient nucleic acid extraction, and responsive ctDNA biosensors. Dr. Yu’s interdisciplinary approach not only expands the utility of MOFs in biomedicine but also paves the way for smart and customizable sensing systems. With 21 high-quality SCI publications and ongoing funded projects, his work is both academically significant and practically relevant in clinical diagnostics and precision medicine.

Publications Top Notes: 

  1.  Lanthanide MOF-Integrated CRISPR-Cas Technology for Amplification-Free Gene Mutation Assay

  2.  Customized Pyrophosphate Nanosensor Based on Lanthanide MOFs for Nucleic Acids Detection

  3.  Polarity Sensor Using Multivariate Lanthanide MOF for Biosensing Platforms

  4.  Levodopa Cascade Polymerization with MOF Nanozyme for Butyrylcholinesterase Dual-Mode Assay

  5.  Enhancing Kinase Detection via Programmable Lanthanide MOF with ATP-to-ADP Conversion

  6. Ultra-Efficient Nucleic Acids Extraction Using Programmable Lanthanide MOF

  7. Bioreaction-Compatible Bivariate Lanthanide MOF Sensor for ctDNA Detection

  8. Adaptable Cobalt MOF for DNA Epigenetic Modification Detection

  9. Trinity Strategy Using Perovskite Nanozyme for Biomarker Reporting

  10.  Nanoporous Crystalline Materials for Nucleic Acids Recognition

Conclusion:

In conclusion, Dr. Long Yu is highly suitable for the Best Researcher Award based on his exceptional research productivity, innovation in the design and application of Ln-MOFs, and substantial contributions to high-impact journals. His early career achievements, particularly as a postdoctoral fellow, show a promising trajectory that is well-aligned with the criteria of research excellence, originality, and potential societal impact. With continued international exposure, broader interdisciplinary collaboration, and efforts to translate research into clinical or industrial outcomes, Dr. Yu is not only deserving of the current award but is also poised to become a leading figure in his field in the years to come.

Yatendra Singh | Plant Metabolomics | Best Researcher Award

Published on by Cell Biologist

Dr. Yatendra Singh | Plant Metabolomics | Best Researcher Award

Dr. Yatendra Singh | University of Mississippi Postdoctoral Research Associate | United States

Dr. Yatendra Singh is an accomplished analytical chemist and postdoctoral researcher at the University of Mississippi, USA. He earned his Ph.D. from CSIR – Central Drug Research Institute, India, where he developed expertise in mass spectrometry and natural product chemistry. With a strong foundation in organic and analytical chemistry, Dr. Singh has actively contributed to the understanding of phytochemicals, bioflavonoids, and cardiac glycosides using cutting-edge chromatographic techniques. His work bridges the fields of pharmacognosy, metabolomics, and cancer pharmacology. He has published widely in reputed journals, highlighting his interdisciplinary approach. At the University of Mississippi, he works under Dr. Sixue Chen, further advancing plant metabolomics. Dr. Singh is known for his diligence, collaboration, and innovation in natural product research. His growing publication record and contributions to therapeutic discovery reflect his promise as a leading figure in the field of analytical and medicinal chemistry.

Publication Profiles: 

Google Scholar
Scopus
Orcid

Education:

Dr. Yatendra Singh’s educational journey reflects a solid progression in chemical and life sciences. He earned his Ph.D. in Analytical Chemistry from CSIR – Central Drug Research Institute, India, where he specialized in ultra-performance liquid chromatography coupled with tandem mass spectrometry (UPLC-MS/MS) for natural product analysis. Before his doctoral studies, Dr. Singh completed his M.S. in Organic Chemistry from M.J.P. Rohilkhand University, India, equipping him with a robust knowledge of chemical synthesis and structure elucidation. His academic foundation began with a B.S. in Zoology and Chemistry, also from M.J.P. Rohilkhand University, which provided an interdisciplinary perspective combining biological and chemical sciences. This diverse academic background allowed him to seamlessly integrate analytical chemistry techniques with pharmacognostic and pharmacological studies, ultimately contributing to novel therapeutic insights. His education has been instrumental in shaping his research trajectory toward impactful discoveries in natural product chemistry.

Experience:

Dr. Yatendra Singh is currently serving as a Postdoctoral Research Associate  in the Department of Biology at the University of Mississippi, under the mentorship of Dr. Sixue Chen. His postdoctoral work focuses on plant metabolomics, mass spectrometry-based compound profiling, and bioactive molecule discovery. During his Ph.D. at CSIR-CDRI, Dr. Singh developed core competencies in analytical chemistry techniques, especially UHPLC-MS/MS and UPLC-QTOF-MS, applying them to study flavonoids, depsides, glycosides, and plant metabolites with pharmacological significance. His research also extended into the pharmacological effects of natural compounds on cancer and inflammation. With an interdisciplinary skill set, Dr. Singh has worked across both chemistry and biology domains, collaborating with pharmacologists, botanists, and analytical scientists. His cumulative academic and postdoctoral experience underscores his strengths in research design, data analysis, compound isolation, and scientific writing, with numerous peer-reviewed publications as evidence of his impactful work in the field.

Awards and Honors:

Dr. Yatendra Singh has been recognized multiple times for his academic excellence and research potential. He was awarded the CSIR – Senior Research Fellowship (SRF) in Chemical Science—one of India’s most competitive fellowships for doctoral research. He received the UGC – Junior Research Fellowship (JRF), and He was awarded the CSIR – JRF, both prestigious fellowships granted based on national-level competitive examinations. These awards reflect his strong academic foundation and his ability to meet the highest standards in research. His contributions to science have not only resulted in high-impact publications but also signify a steady progression in recognition from Indian scientific agencies. His accolades highlight his capability to lead independent research and his commitment to furthering the scientific understanding of natural compounds with therapeutic potential. These fellowships have also provided him with the necessary resources to develop and refine his technical and analytical expertise.

Research Focus:

Dr. Yatendra Singh’s research is centered around the analytical characterization of bioactive natural products using advanced chromatographic and mass spectrometric techniques. He specializes in ultra-performance liquid chromatography (UPLC) coupled with tandem mass spectrometry (MS/MS), employing these tools to explore secondary metabolites in medicinal plants. His work often focuses on flavonoids, cardiac glycosides, depsides, and alkaloids, examining their quantification, seasonal variation, and pharmacological potential. Dr. Singh’s research lies at the interface of analytical chemistry, pharmacognosy, and pharmacology, contributing to the discovery and validation of therapeutic compounds against diseases such as cancer and inflammation. His recent postdoctoral efforts involve plant metabolomics and data-driven compound identification, integrating network pharmacology to predict molecular targets. This integrative approach positions him as a valuable contributor to both basic science and translational research. Through his work, he aims to facilitate the identification of new leads for drug development from natural sources.

Publications Top Notes:

  1. Exploring the pharmacological effect of cardiac glycosides against hepatocellular carcinoma using network pharmacology – Pharmacological Research – Natural Products, 2025

  2. The Purified Fraction of Persicaria capitata Flowers Attenuates Proliferation in A-431 Cell Lines – Pharmacognosy Magazine, 2025

  3. Pharmacognostic Evaluation of Parmelia sulcata Taylor and its Cytotoxic Effects on A Glioblastoma Cell Line – J. of Pharmacology and Pharmacotherapeutics, 2024

  4. Structure analysis of depsides, dibenzofuran and sugar derivatives from Cladia aggregata using UPLC-MS/MS – European Journal of Mass Spectrometry, 2024

  5. Exploration of new and alternative sources of targeted bioflavonoids using UPLC-MS/MS – Separation Science Plus, 2023

  6. Bone fracture-healing properties and UPLC-MS analysis of flavonoid fraction from Oxystelma esculentum – Planta Medica, 2023

  7. Characterization of Dactylorhin and loroglossin in Dactylorhiza hatagirea using UPLC-MS – International Journal of Mass Spectrometry, 2023

  8. Characterization and quantification of Cajanus scarabaeoides phytochemicals using UPLC-MS/MS – Rapid Communications in Mass Spectrometry, 2022

  9. Quantitative evaluation of cardiac glycosides in Nerium oleander using UHPLC-ESI-MS/MS – Phytochemical Analysis, 2022

  10. Aurintricarboxylic acid mitigates cigarette smoke-induced oxidative stress via NF-κB/p65 inhibition – Toxicology Mechanisms and Methods, 2022

Conclusion:

In conclusion, Dr. Yatendra Singh stands out as a talented, driven, and impactful researcher with a remarkable ability to bridge analytical chemistry and pharmacology. His growing record of publications, advanced analytical skills, and strong academic background make him a compelling candidate for the Best Researcher Award. While there is always scope for growth, particularly in research leadership and global outreach, his current achievements reflect excellence, innovation, and dedication. Dr. Singh’s contributions to the discovery and characterization of bioactive natural compounds are timely and relevant, particularly in an era emphasizing sustainable and plant-based therapeutic solutions. Recognizing his efforts through this award would not only honor his individual excellence but also encourage continued high-impact research in areas of significant scientific and societal importance. Dr. Singh embodies the spirit of innovation and academic rigor, making him highly deserving of this recognition.

Shuxin Han | Molecular Mechanisms Signaling | Best Researcher Award

Published on by Cell Biologist

Dr. Shuxin Han | Molecular Mechanisms Signaling | Best Researcher Award

Dr. Shuxin Han | Xinjiang University | China

Dr. Shuxin Han is a distinguished molecular biologist and professor at Xinjiang University, widely recognized for his pioneering work in hepatobiliary and metabolic biology. With a research career spanning over two decades, Dr. Han has made major contributions to understanding how Kruppel-like factors, especially KLF15, regulate endobiotic and xenobiotic metabolism, impacting drug detoxification and metabolic disease mechanisms. He earned his Ph.D. from Kent State University and has held prestigious positions at Harvard Medical School and Case Western Reserve University. His groundbreaking studies have been published in high-impact journals like Nature Metabolism and Nature Communications, with several articles naming him as first or corresponding author. In addition to research, Dr. Han serves as a reviewer for top-tier journals in pharmacology, hepatology, and clinical science. He is also an academic leader, currently shaping the next generation of scientific talent and metabolic disease research in China.

Publication Profile: 

Scopus

Education:

Dr. Shuxin Han began his academic journey in Animal Sciences, earning a bachelor’s degree from Anhui Agricultural University (1994–1998). He advanced to a research assistant role at Peking University (1999–2000), where he deepened his scientific foundation. He then moved to the U.S. to pursue a Master’s in Biology at Temple University (2000–2003), followed by a Ph.D. in Molecular Biology from Kent State University (2004–2009), focusing on metabolic biology and gene regulation. This progression from general animal sciences to highly specialized molecular biology reflects a systematic and deep commitment to biomedical research. His strong academic preparation laid the foundation for a research career investigating how transcriptional regulators impact health and disease. Dr. Han’s training spans world-class institutions across both China and the United States, equipping him with diverse scientific perspectives and techniques.

Experience:

Dr. Shuxin Han has accumulated rich research and academic experience over nearly 30 years. His early career included a pivotal research assistant role at Peking University, followed by advanced training in biology and molecular biology at Temple and Kent State Universities. He completed prestigious postdoctoral training at Harvard Medical School (2009–2012) and Case Western Reserve University (2012–2015), where he later became a Senior Research Associate (2015–2019). He returned to China in 2019 as a Researcher at the University of Science and Technology of China First Affiliated Hospital, simultaneously engaging in academic duties at the university until 2023. Currently, he serves as a Professor and Academic Leader at Xinjiang University. Throughout his career, Dr. Han has built strong international collaborations, led research groups, and guided innovative projects in metabolic biology, demonstrating his leadership, research excellence, and academic mentorship capabilities.

Research Focus:

Dr. Shuxin Han’s research centers on the molecular regulation of metabolism, particularly focusing on the hepatobiliary and gastrointestinal systems. His work has elucidated the critical role of the Kruppel-like factor (KLF) family, especially KLF15, in controlling endobiotic and xenobiotic metabolism (EXM). These pathways govern how the body metabolizes both internal compounds and external substances like drugs. Dr. Han’s studies have shown that KLF15 acts as a master regulator, influencing drug resistance, liver injury, and metabolic homeostasis. His discoveries offer new insight into personalized medicine and treatment for metabolic disorders and drug-related toxicities. With numerous first-author and corresponding-author publications in journals such as Nature Metabolism, Nature Communications, and Drug Metabolism and Disposition, his work has significantly impacted both fundamental science and clinical applications. He is also active in peer-reviewing for top-tier journals and is recognized for his leadership in translational research.

Publications Top Notes:

  1. Unveiling KLF15 as the Key Regulator of Cyclosporine A Metabolism and Adverse Effects – Drug Metabolism and Disposition, 2025

  2. Distribution and Functional Significance of KLF15 in Mouse Cerebellum – Molecular Brain, 2025

  3. Personalized Statin Therapy: Targeting Metabolic Processes – Heliyon, 2025

  4. Current Status and New Directions for Hepatocellular Carcinoma Diagnosis – Liver Research, 2024

  5. KLF15-Cyp3a11 Axis Regulates Rifampicin-Induced Liver Injury – Drug Metabolism and Disposition, 2024

  6. Advancing Drug Delivery and Bioengineering in Liver Research – Bioengineering and Translational Medicine, 2024

  7. Advances in IL-7 Research on Tumor Therapy – Pharmaceuticals, 2024 (Co-author)

  8. Pathogenic Mechanisms in Alcoholic Liver Disease – Journal of Translational Medicine, 2023

  9. Beta-Hydroxybutyrate Effects on iPSC-Derived Cardiac Myocytes – Biomolecules, 2022

  10. Interactions Between Intestinal Flora and Bile Acids – International Journal of Molecular Sciences, 2022 (Corresponding author)

Conclusion:

In conclusion, Dr. Shuxin Han is a highly deserving candidate for the Best Researcher Award. His pioneering work on KLF15 and metabolic regulation has reshaped fundamental understanding in the field of hepatobiliary biology and pharmacology. His academic background, research productivity, international experience, and editorial service all reflect a well-rounded and impactful scientist. While there is room to increase clinical translation and international engagement, the depth, originality, and consistency of his research make him a strong contender for this recognition. Honoring Dr. Han with this award would acknowledge a career dedicated to scientific advancement with substantial implications for human health and drug therapy.

Kwaghgba Elijah Gbabe | Cell Structure Analysis | Best Researcher Award

Published on by Cell Biologist

Dr. Kwaghgba Elijah Gbabe | Cell Structure Analysis | Best Researcher Award

Dr. Kwaghgba Elijah Gbabe | Nigerian Stored Products Research Institute | Nigeria

Engr. Dr. Kwaghgba Elijah Gbabe is a seasoned Senior Research Officer at the Nigerian Stored Products Research Institute (NSPRI), Ilorin, Nigeria. With over nine years of progressive research experience, he specializes in food processing, postharvest technology, and agricultural nanotechnology. He is a trailblazer in developing electrospun hexanal nanofiber matrices aimed at extending the shelf-life of fruits such as bananas, mangoes, and tomatoes. His research integrates innovative preservation technologies to enhance food quality and sustainability. A COREN-certified engineer and postgraduate fellow, Dr. Gbabe has collaborated internationally, notably with the Centre for Agricultural Nanotechnology in India. With extensive publications and conference contributions, he is an advocate of research-driven food security and sustainable packaging. He brings a multidisciplinary edge to the evolving field of agricultural innovation, focusing on reducing postharvest losses and increasing storage efficiency in sub-Saharan Africa.

Publication Profile:

Google Scholar

Strengths for the Award:

  1. Innovative Research in Agricultural Nanotechnology

    • Pioneered the development of electrospun hexanal nanofiber matrices for fruit shelf-life extension — an emerging and impactful technology in food preservation.

  2. Strong Publication Record 

    • Over a dozen peer-reviewed journal articles and conference papers published across international and national platforms with DOIs, indicating high-quality scholarly contribution.

  3. Hands-On International Collaboration 

    • Completed a research internship at TNAU, India, and collaborated with renowned global experts like Prof. K.S. Subramanian in nanoscience.

  4. Multi-disciplinary Skills 

    • Expertise in advanced instrumentation (FTIR, GC-MS, SEM, TEM) and statistical tools (R, SPSS) shows broad technical competence.

  5. Real-world Application & Societal Impact 

    • Focuses on postharvest technologies to reduce food losses, enhance food safety, and support smallholder farmers and artisans.

  6. Leadership and Mentorship

    • Supervises junior staff, fabricators, and trainees, and contributes to capacity building through training workshops.

  7. Recognized Academic Achievement 

    • Recipient of the Benue State University Postgraduate Fellowship (2020–2025).

Areas for Improvement:

  1. Technology Commercialization and Patenting

    • While research output is strong, translating research into commercial products or patents could increase impact.

  2. Broader International Visibility

    • Participation in more international consortia or grants (e.g., EU Horizon, USAID, FAO) could elevate the global footprint.

  3. Expanded Multidisciplinary Outreach

    • Could integrate more with biotech and AI in agri-research, especially in smart packaging and AI-driven postharvest solutions.

Education:

Dr. Gbabe is currently pursuing his Ph.D. in Food Processing and Technology at Benue State University, Makurdi (2020–2025), with a research focus on developing electrospun hexanal nanofiber matrices for fruit preservation. He holds a Master of Engineering in Agricultural and Environmental Engineering from the University of Agriculture, Makurdi (2017–2019), where his thesis explored eco-building materials using rice husk and sawdust. His undergraduate and professional training background is further enhanced by a Certificate in Computer Appreciation (2010), an internship at the Centre for Agricultural Nanotechnology, TNAU, India (2023), and registration with COREN (2024). Dr. Gbabe is also a member of the Nigerian Institution of Agricultural Engineers (NIAE-M2207), demonstrating a strong foundation in both academic knowledge and regulatory standards in engineering and food technology. His educational pursuits reflect a consistent drive toward sustainability, innovation, and technological adaptation in agricultural systems.

Experience:

Dr. Gbabe serves as a Senior Research Officer at NSPRI since 2016, where he leads projects on postharvest technology, storage engineering, and food shelf-life enhancement. His duties span experimental design, research data analysis, technical report writing, equipment fabrication supervision, and stakeholder training. He has been instrumental in developing novel postharvest technologies and electrospun hexanal nanofiber matrices for fruit preservation. In 2023, he completed a research internship at the Centre for Agricultural Nanotechnology, TNAU, India, gaining hands-on experience in nanotoxicity, food nanotechnology, and biosafety. Dr. Gbabe is known for his interdisciplinary collaboration, capacity-building initiatives, and extensive field and lab-based research. He also coordinates training programs for artisans, farmers, and students. His rich professional journey is marked by impactful project execution, community-focused technology dissemination, and consistent contributions to national and international research publications.

Research Focus:

Dr. Gbabe’s research is centered on postharvest loss reduction, sustainable food preservation, and agricultural nanotechnology. He is pioneering the use of electrospun hexanal nanofiber matrices to extend the shelf-life of perishable fruits like bananas, mangoes, and tomatoes—a major advancement in food storage technology. His work addresses the chemical and biological challenges in postharvest handling, integrating advanced techniques such as FTIR, GC-MS, SEM, and TEM to monitor quality and degradation. He is also exploring green materials for packaging and eco-friendly building solutions using agricultural waste like rice husks and sawdust. His international collaboration with TNAU, India, expanded his research in nanotoxicity and food safety. With a focus on experimental design, interdisciplinary innovation, and practical application, Dr. Gbabe contributes to the development of scalable, cost-effective technologies tailored for African agricultural ecosystems. His goal is to enhance food security through intelligent preservation methods and sustainable postharvest engineering.

Publication Top Notes:

  1.  Effect of Hexanal Nano-fiber Matrix on Quality Parameters of Tomato Fruits during Storage

  2.  Development of Novel Hexanal Nano-fibre Matrix by Electrospinning for Shelf-life Extension of Mango Fruits

  3.  Implication of Different Storage Techniques on Physical Attributes of African Okra (Abelmoschus esculentus)

  4.  Maize Grains Milling Efficiency: A Performance Analysis of a Hammer Mill

  5.  Insecticidal and Toxicity Studies of Heliotropium Indicum Leaf Extracts for Stored Grain Pest Control

  6.  Commercial Utilization of Inert Atmosphere Silo for Maize Storage

  7.  Chemical and Physico-chemical Properties of OFSP Chips Dried Using Solar Dryers

  8.  Evaluation of the Use of Rice Husk in Producing Eco-Building Materials

  9.  Pros and Cons of AI Thermal Imaging in Postharvest Handling of Agricultural Products

  10.  Development of Hexanal Electrospun Nano-fiber Matrix for Banana Preservation

Conclusion:

Engr. Dr. Kwaghgba Elijah Gbabe is an exemplary researcher who combines scientific rigor, technological innovation, and practical application in the field of food systems and agricultural engineering. His pioneering work in nanotechnology, coupled with his leadership in postharvest technology, makes him exceptionally deserving of the Best Researcher Award.

Shima Shafiee | Cell Structure Analysis | Best Researcher Award

Published on by Cell Biologist

Dr. Shima Shafiee | Cell Structure Analysis | Best Researcher Award

Dr. Shima Shafiee, Razi University, Iran

Shima Shafiee is an accomplished Iranian researcher specializing in computer systems architecture and bioinformatics, with a strong focus on machine learning applications in biological data analysis. She recently earned her Ph.D. in Computer Engineering from Razi University, where she focused on predictive modeling of protein-peptide binding interactions. Currently under consideration at the IDEL Lab, Shahid Bahonar University of Kerman, Shima has authored numerous national and international publications. With a rich background in algorithm optimization and artificial intelligence, her research stands at the intersection of computational biology, deep learning, and evolutionary algorithms. Shafiee’s work has contributed to the development of predictive tools in bioinformatics, such as DP-site and SPPPred, and she consistently ranks at the top of her academic cohort. Her ability to integrate traditional computer engineering concepts with advanced biological research makes her a notable candidate for the Best Researcher Award.

Publication Profile: 

Google Scholar

Strengths for the Award:

  1. Strong Academic Foundation
    Dr. Shafiee has a stellar academic record, graduating first in her Ph.D. class at Razi University with a CGPA of 3.77 and a thesis grade of 3.98, under the supervision of respected experts in computer engineering and bioinformatics.

  2. Innovative Interdisciplinary Research
    Her research bridges computer systems architecture, machine learning, and bioinformatics, with notable contributions to protein-peptide binding prediction, a critical domain in drug discovery and computational biology.

  3. High-Impact Publications
    She has published in IEEE/ACM Transactions, Applied Soft Computing, and Methods, reflecting both quality and visibility in international forums. Tools like SPPPred and DP-site demonstrate her practical impact in bioinformatics.

  4. Research Originality and Versatility
    Dr. Shafiee has developed hybrid models combining genetic programming, support vector machines, and deep learning, with practical tools and open-source contributions.

  5. Early Recognition and Outreach
    She has been active in academic dissemination since 2015, with selected papers in national and international conferences, showing early promise and consistency.

  6. Teaching and Mentorship
    Through her roles as a lecturer at multiple institutions, she has contributed to academic growth at the grassroots level.

Areas for Improvement:

  1. International Collaboration & Visibility
    While her publication quality is strong, Dr. Shafiee could expand her global visibility through collaborations with international research labs, EU Horizon, or NIH-funded projects.

  2. Post-Ph.D. Grant Applications
    She could benefit from applying for independent research grants or postdoctoral fellowships to lead projects that could shape the future of AI in biology.

  3. Open-Source Software and Data Availability
    While her models are impactful, increased accessibility via open-source repositories (e.g., GitHub) would boost reproducibility and encourage broader adoption.

  4. Industry Impact Metrics
    More emphasis on industry collaborations, patents, or application of models in clinical/biotech settings would enhance translational impact.

Education:

Shima Shafiee completed her Ph.D. in Computer Engineering (2016–2024) from Razi University, specializing in Computer Systems Architecture. Her dissertation titled “Application of learning-based models in predicting of protein-peptide binding interactions” earned her a thesis grade of 3.98/4.00 and an overall CGPA of 3.77. She worked under the guidance of Dr. Abdolhossein Fathi and Dr. Ghazaleh Taherzadeh, focusing on bioinformatics using deep learning, ensemble learning, and evolutionary algorithms. Prior to her Ph.D., she was ranked third in her Master’s program (2015). Shafiee’s educational background is rooted in computational problem-solving, algorithm development, and cross-disciplinary research involving biological data. Her consistent academic excellence and high-ranking performance culminated in her being recognized as the top Ph.D. student in 2025, a testament to her dedication and scholarly capabilities. Her education blends rigorous theory with innovative applied research, making her exceptionally well-prepared for high-impact contributions in academia and industry.

Experience:

Shima Shafiee’s experience spans both academic and applied computer engineering roles. She began her journey with an internship at Kimia Pardaz Pars Company (2013). Between 2015 and 2016, she served as a lecturer for computer fundamentals at Fajr High School and Al-Zahra Seminary School in Jiroft, where she taught introductory computer science to pre-university students. These experiences highlight her foundational teaching skills and outreach to educational institutions in her community. Her major academic contribution began during her Ph.D., where she collaborated with IDEL Lab and contributed to developing tools like SPPPred and DP-site, combining genetic programming, support vector machines, and deep learning to predict protein-peptide binding regions. Her experience uniquely blends educational outreach, algorithmic development, and publication-driven research in machine learning, optimization, and computational biology, reflecting her versatility and impact across the scientific and academic spectrum.

Awards & Honors:

Shima Shafiee has earned multiple distinctions recognizing her academic and research excellence. In 2015, she was named the third-place student in her Master’s program, demonstrating early academic excellence. Her continuous dedication to research and scholarship led her to be recognized as the first-place student in her Ph.D. program in 2025. One of her papers was selected at the 2nd International Congress of Electrical Engineering, Computer Science, and Information Technology (2015), highlighting the innovation and relevance of her early research in optimization algorithms. Her high publication output, including appearances in top-tier venues like IEEE/ACM Transactions on Computational Biology and Bioinformatics and Applied Soft Computing, reflects a consistent standard of excellence. These honors collectively showcase her as a standout figure in her field, with both academic and applied contributions acknowledged at national and international levels.

Research Focus:

Shima Shafiee’s research lies at the intersection of machine learning, bioinformatics, and computational systems engineering. Her primary focus is the prediction of protein-peptide binding interactions using intelligent algorithms such as genetic programming, ensemble models, and deep learning techniques. She has proposed several innovative hybrid models combining sequence-based and structure-based features to identify critical interaction residues. Her doctoral thesis and publications have led to the development of tools like SPPPred and DP-site, which aid in biological sequence analysis, with applications in drug discovery, protein function prediction, and biomedical engineering. Shafiee also has a strong background in optimization algorithms, especially particle swarm optimization (PSO), applied to computationally intensive problems like bin packing. Her ability to blend theoretical computing with practical biological data analysis makes her contributions valuable to both computational scientists and biologists, and positions her as a leading candidate for research recognition awards in AI and bioinformatics.

Publications Top Notes: 

  • 🧠 SPPPred: sequence-based protein-peptide binding residue prediction using genetic programming and ensemble learning (IEEE/ACM TCBBS, 2022)

  • 🔍 Prediction of protein–peptide-binding amino acid residues regions using machine learning algorithms (CSICC, 2021)

  • 🧬 Combination of genetic programming and SVM-based prediction of protein-peptide binding sites (Journal of Computing and Security, 2021)

  • 🧪 Prediction of protein–peptide binding residues using classification algorithms (IEEE Bioengineering Conf, 2020)

  • 🧠 A Review of the Uses of AI in Protein Research (Peptide Science Conf, 2019)

  • 🤖 DP-site: dual deep learning method for protein-peptide interaction site prediction (Methods, 2024)

  • 🧬 Protein-peptide interaction region prediction using generative sampling & ensemble DL (Applied Soft Computing, 2025)

  • 🧠 Comparing classification vs. segmentation predictors in protein-peptide interaction (CSICC, 2025)

  • 🧬 Leveraging structure-based and learning-based predictors in protein-peptide interaction (ICCKE, 2024)

  • 📘 Application of learning-based models in protein-peptide binding (Ph.D. Dissertation, 2024)

Conclusion:

Dr. Shima Shafiee is a highly suitable candidate for the Best Researcher Award based on her academic excellence, interdisciplinary research achievements, and consistent contributions to the fields of artificial intelligence and bioinformatics. Her ability to bridge computer science and biological challenges has resulted in meaningful and applicable solutions. She has displayed originality, depth, and foresight in her work, developing novel methods that align with modern computational biology trends.

Maria Andriolo | Host-Pathogen Interactions | Best Innovation Award

Published on by Cell Biologist

Dr. Maria Andriolo | Host-Pathogen Interactions | Best Innovation Award

Dr. Maria Andriolo, ASP CALTANISSETTA, Italy

Maria Andriolo is a dedicated biomedical researcher and clinical biologist with extensive experience in neuroscience, immunology, and post-traumatic disorders. Her multidisciplinary approach has led to impactful contributions in clinical diagnostics, neurorehabilitation, and infectious disease studies. With decades of experience across leading Italian institutions, she combines clinical insight with scientific rigor. She has served in prestigious roles such as a Member of the State Examination Commission and President of Public Selection Committees. Dr. Andriolo is widely published, collaborating on pioneering studies in fields including brain trauma, sepsis diagnostics, and vaccine immunoresponse. Known for her collaborative spirit and leadership, she also contributes as a conference moderator and educator. Her body of work reflects a deep commitment to translational science that benefits patient care and public health.

Publication Profile:

Scopus

✅ Strengths for the Award:

  1. Multidisciplinary Research Impact
    Dr. Andriolo’s work spans key medical research areas including:

    • Neurology (e.g., traumatic brain injury, disorders of consciousness)

    • Clinical Biochemistry (e.g., neuron-specific enolase, BDNF, CSF biomarkers)

    • Microbiology & Infectious Diseases (e.g., antimicrobial resistance, sepsis diagnostics)

    • Immunology & Vaccine Response (e.g., post-COVID vaccine serology in healthcare workers)

  2. Innovation with Real-World Impact
    Her studies focus on biomarkers for rapid diagnosis, rehabilitation outcomes, and immune responses, directly translating into improved patient care, particularly in:

    • Post-traumatic brain disorders

    • Early detection of sepsis

    • Infection control strategies

  3. Collaborative and High-Impact Publications

    • Extensive peer-reviewed articles in PubMed-indexed journals like Journal of Neurotrauma, Brain Sciences, Vaccines, and Science Reports.

    • Publications show collaborations with leading national research teams and hospitals.

  4. Scientific Leadership & Recognition

    • Appointed as President of National Selection Committees and State Examiner for Biologist Certification.

    • Served as Moderator at ECM Conferences, further demonstrating peer trust and scientific communication skills.

⚠️ Areas for Improvement:

  1. Lead Authorship and Project Ownership

    • While her publication record is strong, she is mostly listed as co-author. Clear documentation of principal investigator roles, research grants led, or independent innovation patents would further bolster her candidacy.

  2. International Presence

    • A broader international profile (e.g., global conferences, cross-border collaborative studies, citations from non-EU entities) could elevate her global impact.

  3. Recent Innovation Highlights

    • A focused submission highlighting a single groundbreaking innovation (e.g., biomarker panel for TBI prognosis or rapid sepsis tool) would align more clearly with “Best Innovation” award criteria.

🎓 Education:

While the detailed educational background isn’t listed, Maria Andriolo’s professional and scientific achievements imply a robust academic foundation in Biology, Neuroscience, and Clinical Diagnostics, likely culminating in at least a Master’s or Doctorate-level education in Biomedical Sciences. Her involvement as a State Examiner for Biologist Qualification and leader of academic committees suggests a longstanding connection with university-level institutions, particularly the University of Messina. Given her expertise and publication record, it is evident she has received specialized training in neurobiology, molecular genetics, clinical chemistry, and medical microbiology. She has actively participated in ECM-accredited medical conferences, indicating a commitment to continuing professional development. This mix of structured education and applied training positions her as a highly qualified scientific professional.

💼 Professional Experience:

Maria Andriolo holds significant academic and clinical leadership roles. She was appointed in July 2024 as a Member of the State Examination Commission for Biologists at the University of Messina, overseeing professional certifications. In June 2023, she served as President of the Examination Committee for a public selection competition for C1 research staff. She is frequently invited to act as a moderator at ECM-accredited conferences, underscoring her peer recognition in the field. Her expertise spans biomedical research, academic evaluation, and public health diagnostics. Maria’s ability to combine scientific knowledge with regulatory oversight and teaching makes her a valuable contributor to academia and public institutions. Her leadership and participation in national scientific initiatives demonstrate her commitment to innovation, clinical application, and academic excellence.

🔬 Research Focus:

Maria Andriolo’s research is anchored in neuroscience, post-traumatic disorders, biomarkers, and infectious diseases. Her work often centers on patients with disorders of consciousness following trauma, analyzing biomarkers like BDNF, neurofilaments, and amyloid-beta proteins. She is a leading contributor in understanding the neurochemical pathways associated with brain injury and rehabilitation. Maria has also co-authored influential studies on sepsis diagnostics, immune response to COVID-19 vaccines, and antimicrobial resistance. Her research combines laboratory diagnostics with clinical applications, enabling faster diagnoses and more effective treatment strategies. She is known for utilizing multidisciplinary frameworks, involving neurologists, microbiologists, and clinicians to translate science into solutions. This strong translational impact underscores her candidacy for the Best Innovation Award, as she bridges the gap between research and patient-centered innovation.

📚 Publications Top Notes:

  1. 🧠 Reduced neuron-specific enolase levels in chronic severe traumatic brain injury

  2. 🧬 Multidisciplinary approach for the rapid diagnosis of sepsis

  3. 💉 Serological analysis of humoral immune response in Sicilian HCWs post-COVID vaccination

  4. 🧠 Dissociation of CSF amyloid-beta and tau in post-traumatic consciousness disorders

  5. 💉 Staphylococcus aureus in bloodstream infections: frequency & antimicrobial resistance

  6. 🧠 Serum BDNF levels are reduced in disorders of consciousness

  7. 🧠 Six-month outcomes in traumatic consciousness disorders (hemorrhagic/non-hemorrhagic)

  8. 🧠 BDNF Val66Met polymorphism and post-traumatic vegetative state recovery

  9. 💉 Anaphylaxis to streptomycin

  10. 🧠 Prolonged CSF neurofilament light chain increase in traumatic brain patients

🏁 Conclusion:

Maria Andriolo is a highly suitable and deserving candidate for the Research for Best Innovation Award. Her research demonstrates:

  • Exceptional depth in translational neuroscience and diagnostics

  • A strong commitment to multidisciplinary collaboration

  • A clear track record of innovation that impacts both patient outcomes and healthcare protocols

 

 

 

ALINE TAKEJIMA | Tissue engineering | Women Researcher Award

Published on by Cell Biologist

Dr. ALINE TAKEJIMA | tissue engineering | Women Researcher Award

Dr. ALINE TAKEJIMA, pontificia universidade catolica do parana, Brazil

Dr. Aline Luri Takejima is a physician-scientist from Brazil, specializing in regenerative medicine and wound healing. She holds an MD and a PhD in Health Sciences from the Pontifical Catholic University of Paraná (PUCPR), where she currently conducts postdoctoral research. With a focus on biological therapies involving the amniotic membrane, Wharton’s jelly, and mononuclear stem cells, Dr. Takejima has published in multiple high-impact scientific journals. Her research aims to develop novel regenerative strategies to treat complex wounds and enhance tissue repair. As an active member of PUCPR’s Wound Healing Research Group and the Brazilian Society of Plastic Surgery, she combines scientific rigor with clinical insight to bridge bench-to-bedside innovation. Her academic contributions are guided by a translational approach, offering promising avenues for future clinical applications in tissue engineering.

Publication Profile: 

Orcid

✅ Strengths for the Award:

  1. Focused Research Excellence:
    Dr. Takejima’s work on biological scaffolds and stem cells in wound healing is both innovative and clinically relevant. Her studies using amniotic membrane, Wharton’s jelly, and bone marrow mononuclear cells show promising regenerative outcomes in preclinical models.

  2. Research Productivity:
    With 9 peer-reviewed journal articles in high-quality platforms (e.g., Biomedicines, Tissue Barriers, Annals of Biomedical Engineering), she demonstrates consistent academic output in her field.

  3. Translational Impact:
    Her research bridges basic science and clinical practice, aiming to provide regenerative solutions for patients with chronic wounds and cardiac damage.

  4. Collaborative Engagement:
    Active participation in a multidisciplinary wound healing research group, contributing to cross-functional scientific advancements.

  5. Recognition Potential:
    As a young, emerging woman researcher in biomedical sciences, she stands as a role model for future female scientists in Latin America and beyond.

🔧 Areas for Improvement:

  1. Intellectual Property & Innovation:
    No patents filed yet; transitioning her research into patentable therapies or commercial applications would increase its societal and economic impact.

  2. Leadership Roles:
    While active in research, taking on editorial or scientific leadership positions would enhance her academic visibility and influence.

  3. Internationalization:
    She would benefit from developing international collaborations or fellowships to diversify her research scope and increase global reach.

  4. Industry Engagement:
    Engaging in consultancy or biotech partnerships can further the translational impact of her regenerative strategies.

🎓 Education:

Dr. Takejima’s educational journey began with a Doctor of Medicine (MD) degree from the Pontifical Catholic University of Paraná (PUCPR), Brazil. Her passion for research led her to pursue a Doctorate (PhD) in Health Sciences/Medicine, also at PUCPR. Her doctoral thesis focused on the use of biologically active materials such as the amniotic membrane and stem cells to enhance wound healing. Throughout her academic training, she demonstrated a strong commitment to translational medicine by integrating basic science with clinical practice. During her PhD, she engaged in experimental models involving stem cell therapy and tissue engineering, which laid the groundwork for her current postdoctoral research. Her educational path reflects both depth and specialization in the biomedical sciences, particularly in regenerative medicine and cellular therapies.

💼 Experience:

Dr. Aline Takejima has over a decade of experience in medical and scientific fields, balancing her role as a physician with that of a postdoctoral researcher. Her clinical background informs her research, particularly in areas of wound healing and regenerative medicine. At PUCPR, she contributes to the Wound Healing Research Group, where she is involved in designing and conducting animal model studies to test the effects of biomaterials and stem cells. Her multidisciplinary research integrates immunology, histopathology, and molecular biology. With nine peer-reviewed publications and participation in collaborative research, she has become a respected contributor to the field. Though early in her research career, her trajectory shows a steady rise, marked by evidence-based outcomes and a commitment to innovation. Her goal is to bridge clinical challenges with regenerative solutions that can be implemented in real-world medical practice.

🔬 Research Focus:

Dr. Takejima’s research focuses on regenerative strategies for wound healing, utilizing biomaterials and stem cells. Her work primarily explores the application of amniotic membrane, Wharton’s jelly, and bone marrow-derived mononuclear stem cells in treating complex or chronic skin wounds. Using experimental models in rats and rabbits, she evaluates histological recovery, inflammation modulation, and tissue regeneration. A significant aspect of her research is understanding how these materials promote healing through paracrine effects rather than direct integration, offering a safer and scalable pathway to clinical application. Additionally, her work extends to cardiac and tracheal tissue repair, emphasizing the versatility of these regenerative approaches. The translational nature of her research bridges laboratory discoveries with potential bedside applications, positioning her at the forefront of cellular therapy and biomaterials science.

📚 Publications Top Notes:

  1. 🧠 Wharton’s Jelly Bioscaffolds Improve Cardiac Repair with Bone Marrow Mononuclear Stem Cells in Rats – Journal of Functional Biomaterials, 2025

  2. 🧫 The effects of decellularized amniotic membrane and Wharton’s jelly on the healing of experimental skin wounds in rats – Tissue Barriers, 2025

  3. ❤️ Bone-marrow mononuclear cells and acellular human amniotic membrane improve global cardiac function… – Anais da Academia Brasileira de Ciências, 2024

  4. 🫁 Tracheal regeneration with acellular human amniotic membrane and 15d-PGJ2 nanoparticles in rabbits – Anais da Academia Brasileira de Ciências, 2023

  5. 🧬 Acellular Biomaterials + Autologous Stem Cells Improve Wound Healing via Paracrine Effects – Biomedicines, 2023

  6. 💉 Decellularized Amniotic Membrane Solubilized with Hyaluronic Acid in Wound Healing – Annals of Biomedical Engineering, 2022

  7. 🧪 Role of Mononuclear Stem Cells and Decellularized Amniotic Membrane in Skin Wounds – Tissue Barriers, 2022

  8. 🏥 Trauma hepático: epidemiologia de cinco anos… – Revista do Colégio Brasileiro de Cirurgiões, 2008

🧾 Conclusion:

Dr. Aline Luri Takejima is an outstanding candidate for the Women Researcher Award. Her academic profile demonstrates a strong foundation in regenerative medicine with significant contributions to wound healing research. Her commitment to applying biological therapies in clinical contexts shows both depth and innovation. As a woman scientist in a competitive field, she exemplifies leadership, dedication, and potential. With further growth in global engagement and innovation strategy, Dr. Takejima is poised to become a future leader in regenerative biomedical research.

Rodrigo Navarro | Tissue Engineering | Tissue Engineering Award

Published on by Cell Biologist

Dr. Rodrigo Navarro | Tissue Engineering | Tissue Engineering Award

Dr. Rodrigo Navarro, Institute of Polymer Science and Technology, Spain

Dr. Rodrigo Navarro Crespo is a Tenured Scientist at the Spanish National Research Council (CSIC), specializing in polymer science and materials chemistry. With a solid foundation in chemistry and an internationally-recognized research profile, he has contributed significantly to the development of advanced polymeric materials with environmental and biomedical applications. His scientific work focuses on sustainable materials, plasticizer migration suppression, polymer surface modification, and chemical recycling. Dr. Navarro has published extensively in high-impact journals and collaborated with researchers across Europe. His ability to innovate in polymer processing, particularly through green chemistry and circular economy principles, positions him at the forefront of modern materials science. In 2020, he was awarded the Best Paper Award by the European Membrane Society. Dr. Navarro’s experience, interdisciplinary mindset, and research excellence make him a strong candidate for recognition in fields like tissue engineering, where advanced and sustainable polymer design is increasingly critical.

Publication Profile: 

Google Scholar

✅ Strengths for the Award:

  1. Interdisciplinary Expertise: Dr. Navarro’s research integrates polymer chemistry, materials science, and green chemistry, which are highly relevant for tissue engineering. His expertise in designing bio-inspired polyurethanes and non-migrating plasticized polymers aligns with the need for biocompatible, durable, and safe scaffolding materials in regenerative medicine.

  2. Innovation in Polymer Modification: His work on PVC modification, covalent plasticizer bonding, and functional surface-attached polymer layers demonstrates strong potential for developing customized materials with controlled biodegradability and mechanical properties suitable for tissue scaffolds.

  3. Environmental Sustainability Focus: His award-winning contributions to the circular economy, especially the upcycling of PET and membrane recycling, show leadership in sustainable material innovation — a growing priority in biomedical applications.

  4. Publication Impact & Recognition: With highly cited publications in Macromolecules, Langmuir, and Journal of Membrane Science, and the 2020 Best Paper Award, he is a well-recognized expert in polymer systems, which strengthens his academic profile for any prestigious research award.

📌 Areas for Improvement:

  1. Direct Application to Tissue Engineering: While his research strongly supports materials design, there’s limited direct evidence of his work being applied in biological systems such as cell culture, in vivo testing, or tissue integration studies. Expanding collaborations with biomedical researchers or publishing in biomedical journals could solidify his relevance in tissue engineering.

  2. Translational Research Output: Most contributions are fundamental or materials-based; showcasing functional prototypes, patents, or clinical collaborations would boost his impact in the translational science domain where tissue engineering advances often occur.

  3. Broader International Leadership: While experienced and internationally trained, more visibility in international tissue engineering consortia, symposia, or editorial roles in biomedical journals could help affirm his leadership in this interdisciplinary field.

🎓 Education:

Rodrigo Navarro Crespo began his academic career with a BSc in Chemistry from the University of Valladolid (Spain) in 2004, earning distinction. He then pursued a PhD in Chemistry at the Complutense University of Madrid, completing it in 2009, also with distinction. His doctoral research focused on developing functional polymers, laying the groundwork for a research career centered on advanced polymer chemistry and materials science. Dr. Navarro has consistently aimed to integrate fundamental chemistry with applied research, which is evident from his later involvement in high-level research projects in Germany and Spain. His educational path reflects a strong commitment to academic excellence and international collaboration. The combination of chemical synthesis, polymer engineering, and sustainable materials has equipped him with a versatile and interdisciplinary academic foundation, ideally suited for innovation in tissue engineering and biomaterials science.

💼 Experience:

Dr. Navarro’s professional journey started as a PhD student at the Instituto de Ciencia y Tecnología de Polímeros (CSIC) from 2004 to 2008. Post-PhD, he worked in Germany at the Institut für Mikrosystemtechnik (IMTEK) (2009–2010), gaining international experience in microsystems and surface modification. Since 2024, he holds a Tenured Scientist position at CSIC, where he leads innovative projects in polymer chemistry. Over his career, he has developed and characterized novel polymeric materials with diverse applications — from biocompatible films and recyclable polymers to smart functional materials. His multidisciplinary experience spans academic research, applied polymer development, and international cooperation. Dr. Navarro’s blend of theoretical knowledge and hands-on research excellence has made him a key figure in advancing sustainable polymer solutions for real-world challenges, aligning well with emerging areas like tissue engineering.

🏅 Awards and Honors:

  • 🎓 Distinction in Chemistry Degree – University of Valladolid, 2002

  • 🎓 Distinction in PhD Chemistry – Complutense University of Madrid, 2009

  • 🏆 Best Paper Award (2020) – European Membrane Society for a publication in Journal of Membrane Science on circular economy and membrane recycling
    Dr. Navarro’s academic distinctions highlight his strong foundational capabilities in chemistry, and his Best Paper Award demonstrates peer-recognized innovation in sustainability-focused research. His scholarly impact is further emphasized by the high citation count of multiple papers, especially in areas like polymer plasticizers and membrane technologies. These recognitions underscore his dedication to impactful, high-quality research — a key qualification for awards in cutting-edge fields such as tissue engineering.

🔬 Research Focus:

Dr. Rodrigo Navarro Crespo’s research centers on advanced polymeric materials with sustainable, functional, and biomedical properties. A core focus has been the modification of PVC and polyurethanes to reduce plasticizer migration — a significant health and environmental issue. He has also developed novel bio-inspired materials, recyclable membranes, and upcycled polyesters, contributing to the circular economy. His work emphasizes green chemistry, high-performance coatings, and functional surfaces, employing photochemical and thermal methods to tailor polymer properties. His recent research aligns with key tissue engineering needs: biocompatibility, controlled degradation, and mechanical robustness. Through collaborative projects, interdisciplinary innovation, and a publication portfolio spanning membrane science, degradation stability, and polymer nanocomposites, Dr. Navarro addresses global challenges like plastic waste and biomedical material safety. His expertise is well-suited to tissue engineering applications where materials science, sustainability, and biofunctionality converge.

📚 Publications Top Notes:

  1. 📄 Phthalate plasticizers covalently bound to PVC: plasticization with suppressed migration – Macromolecules, 2010

  2. 📄 Preparation of surface-attached polymer layers by thermal or photochemical activation of α-diazoester moieties – Langmuir, 2013

  3. 📄 Highly flexible PVC materials without plasticizer migration via trichlorotriazine chemistry – Macromolecules, 2016

  4. 📄 New routes to difunctional macroglycols using ethylene carbonate – Polymer Degradation and Stability, 2017

  5. 📄 Design and synthesis of bio-inspired polyurethane films with high performance – Polymers, 2020

  6. 📄 Coumarins into polyurethanes for smart and functional materials – Polymers, 2020

  7. 🏆 Circular economy in membrane technology: Recycling end-of-life reverse osmosis modules – Journal of Membrane Science, 2020

  8. 📄 Preparation of high molecular weight poly(urethane-urea)s bearing deactivated diamines – Polymers, 2021

  9. 📄 Properties of polyurethanes from poly(diethylene glycol terephthalate) – European Polymer Journal, 2021

  10. 🔄 Chemical upcycling of PET waste: Moving to a circular model – Journal of Polymer Science, 2022

🧾 Conclusion:

Dr. Rodrigo Navarro Crespo is a highly qualified and promising candidate for a Research for Tissue Engineering Award, particularly from the materials development and sustainability angle. His original contributions in polymer chemistry, especially in bio-inspired and functional polymers, offer real value to regenerative medicine through safer, smarter, and more environmentally responsible biomaterials.